DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

GlaxoSmithKline (NYSE: GSK)

47.38 0.09 (0.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $47.38 0.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.60
Previous Close $47.29
Daily Range $47.37 - $47.69
52-Week Range $46.01 - $56.73
Market Cap $113.8B
P/E Ratio 16.25
Dividend (Yield) $2.59 (5.6%)
Ex-Dividend Date
Dividend Pay Date
08/06/14
10/02/14
Volume 7,925,388
Average Daily Volume 3,621,813
Current FY EPS $3.18

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

Why Sarepta Therapeutics Inc. Stock Soared By 17% in 2014

Sarepta Therapeutics stock has been whipsawed over the past year. Find out what's been the cause of its volatility and whether or not the stock can head higher.

How Will GlaxoSmithKline (GSK) Stock Be Affected By This Lawsuit?

It Takes Less Than 15 Minutes To Buy VVUS Shares!

U.S. stocks: Futures higher as Fed rate view holds

European Stocks, Pound Rise After Scots Reject Independence

China fines GSK $490 million, sentences exec over bribery

China fines GlaxoSmithKline nearly $500 million for bribery

GlaxoSmithKline convicted of bribery in China, ordered to pay half billion fine

Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment

Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog

After Hours Most Active for Sep 17, 2014 : GSK, QQQ, BAC, PSX, KORS, SQNM, FOXA, INTC, PIR, RFMD, P

After Hours Most Active for Sep 17, 2014 : GSK, QQQ, BAC, PSX, KORS, SQNM, FOXA, INTC, PIR, RFMD, PLCM, MHK

Could GlaxoSmithKline Be A Better Investment Than Gilead?

See More GSK News...

GSK's Top Competitors

GSK $47.38 (0.19%)
Current stock: GSK
JNJ $107.99 (0.60%)
Current stock: JNJ
NVS $93.90 (-0.95%)
Current stock: NVS
RHHBY $37.64 (-0.70%)
Current stock: RHHBY